Similar articles for PMID: 12933918

Year	Number of Results
1994	1
1997	1
1999	1
2000	2
2001	3
2002	1
2003	1
2004	2
2005	2
2006	2
2007	5
2008	6
2009	5
2010	5
2011	7
2012	9
2013	6
2014	8
2015	13
2016	9
2017	8
2018	3
2019	3
2020	5
2021	3
2023	1
2024	0

1

Intrathecal inflammation precedes development of Alzheimer's disease.

Tarkowski E, Andreasen N, Tarkowski A, Blennow K. Tarkowski E, et al. J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1200-5. doi: 10.1136/jnnp.74.9.1200. J Neurol Neurosurg Psychiatry. 2003. PMID: 12933918 Free PMC article.

2

Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.

Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L. Sundelöf J, et al. J Alzheimers Dis. 2010;21(2):471-8. doi: 10.3233/JAD-2010-091594. J Alzheimers Dis. 2010. PMID: 20555147

3

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K. Mattsson N, et al. JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064. JAMA. 2009. PMID: 19622817

4

Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.

Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, Dallob A, Chappell D, Snyder K, Flynn M, Simon A, Modur V, Potter WZ, Wilcock G, Savage MJ, Smith AD. Seeburger JL, et al. J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725. J Alzheimers Dis. 2015. PMID: 25391385

5

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.

Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Ben Bouallègue F, et al. Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 10.1186/s13195-017-0260-z. Alzheimers Res Ther. 2017. PMID: 28441967 Free PMC article.

6

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.

Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O. Buchhave P, et al. Arch Gen Psychiatry. 2012 Jan;69(1):98-106. doi: 10.1001/archgenpsychiatry.2011.155. Arch Gen Psychiatry. 2012. PMID: 22213792

7

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

Hampel H, Teipel SJ, Fuchsberger T, Andreasen N, Wiltfang J, Otto M, Shen Y, Dodel R, Du Y, Farlow M, Möller HJ, Blennow K, Buerger K. Hampel H, et al. Mol Psychiatry. 2004 Jul;9(7):705-10. doi: 10.1038/sj.mp.4001473. Mol Psychiatry. 2004. PMID: 14699432

8

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.

Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, De Santi S, Zinkowski R, Mehta P, Pratico D, Saint Louis LA, Wallin A, Blennow K, de Leon MJ. Brys M, et al. Neurobiol Aging. 2009 May;30(5):682-90. doi: 10.1016/j.neurobiolaging.2007.08.010. Epub 2007 Sep 24. Neurobiol Aging. 2009. PMID: 17889968 Free PMC article.

9

Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.

Maccioni RB, Lavados M, Guillón M, Mujica C, Bosch R, Farías G, Fuentes P. Maccioni RB, et al. Neurobiol Aging. 2006 Feb;27(2):237-44. doi: 10.1016/j.neurobiolaging.2005.01.011. Epub 2005 Apr 7. Neurobiol Aging. 2006. PMID: 16399209

10

Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.

Sarlus H, Eyjolfsdottir H, Eriksdotter M, Oprica M, Schultzberg M. Sarlus H, et al. J Alzheimers Dis. 2015;48(2):495-505. doi: 10.3233/JAD-143147. J Alzheimers Dis. 2015. PMID: 26402013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year